Abstract:Purpose/objectives: Primary small cell esophageal carcinoma (SCEC) is a rare malignancy without an established treatment strategy. This study investigated the gene expression profile of SCEC and compared it with the expression profiles of small cell lung cancer (SCLC) and esophageal adeno/squamous carcinoma (EAC/ESCC). Materials/methods: All patients with SCEC, SCLC, and EAC/ESCC in the Surveillance, Epidemiology, and End Results (SEER) database 1973-2014 were included. Overall survival (OS) and prognostic analysis were conducted. De novo expression array analysis was performed on three pairs of frozen primary SCEC tissues and the corresponding normal samples from the institutional tissue bank using the Affymetrix HG U133 plus 2.0 Array. These data were complemented with public domain expression data sets from the Gene Expression Omnibus (GEO) repository using the same working platforms, which included primary SCLC, EAC/ESCC, and normal lung/esophagus specimens (series GSE30219 and GSE26886). After individual normalization, the primary tumors were submitted to statistical analysis (GeneSpring GX 13.0) to identify the differentially expressed genes (DEGs) relative to their paired normal tissues. Enrichments of genes categorized by function and gene interactions were analyzed by DAVID 6.8 and STRING 11.0, respectively. Results: The clinical outcomes of the patients with SCEC were significantly more worse than those with EAC/ESCC and SCLC in the SEER database. SCEC had more DEGs in common with SCLC than EAC/ESCC [829 vs. 450; false discovery rate (FDR) < 0.01; and fold change ≥2], leading to a stronger correlation between SCEC and SCLC (Pearson's correlation coefficient was 0.60 for SCEC vs. SCLC, 0.51 or 0.45 for SCEC vs. ESCC or EAC, and the coefficient was 0.73 for ESCC vs. EAC). Similar findings were obtained by principal component analysis (PCA) using all DEGs retrieved from these four groups. Functional annotation showed that a higher proportion of pathways and biological processes were common between SCEC and SCLC and were associated with the cell cycle (mitosis), DNA replication, telomere maintenance, DNA repair, and P53 and RB pathways (Benjamini p < 0.05). Compared with EAC/ESCC, SCEC shared more co-upregulated DEGs coding for the aforementioned common pathways with SCLC (584 vs. 155). In addition, SCEC and SCLC were found to have possessed overlapping gene-interactive networks, with centromere protein F (CENPF), never in mitosis gene A-related kinase 2 ( NEK2), kinesin family member 11 (KIF11), thymopoietin (TMPO), and forkhead box protein M1 (FOXM1) as common skeletons centered by gene regulatory network (NUF2). Conclusions: This study is the first attempt to examine the genomic signatures of SCEC at the transcriptomic level and compare the expression profiles between SCEC, SCLC, and EAC/ESCC. Our preliminary data indicate that SCEC and SCLC display notably similar patterns of gene expression for mitosis and DNA repair. Further validation studies are warranted.

A Comparative Analysis of Clinicopathological Factors and Survival Between Esophageal Basaloid Squamous Cell Carcinoma and Conventional Esophageal Squamous Cell Carcinoma.

Comparison of Clinical and Prognostic Characteristics Between Superficial Basaloid and Conventional Esophageal Squamous Carcinoma

Clinicopathological and Prognostic Characteristics of Esophageal Spindle Cell Squamous Cell Carcinoma: An Analysis of 43 Patients in a Single Center

A Retrospective Study of Different Treatments of Limited-Stage Small-Cell Esophageal Carcinoma and Associated Prognostic Factor Analysis

Comparison of Clinicopathologic Features and Survival Between Eastern and Western Population with Esophageal Squamous Cell Carcinoma.

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy

Extrapulmonary Small Cell Carcinoma: Clinical and Prognostic Analysis

A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma

A 10-Year Population-Based Study of the Differences Between NECs and Carcinomas of the Esophagus.

Submucosal gland differentiation and implications in esophageal basaloid squamous cell carcinomas

The integrated molecular and histological analysis defines subtypes of esophageal squamous cell carcinoma

Independent Prognostic Role of PD-L1expression in Patients with Esophageal Squamous Cell Carcinoma.

[A Histopathologic and Immunohistochemical Study of Prognostic Factors in Esophageal Squamous Cell Carcinoma].

A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions

Endoscopic Submucosal Dissection Versus Esophagectomy for T1 Esophageal Squamous Cell Carcinoma: a Propensity Score-Matched Analysis

Comparison of the Prognostic Difference Between Yptnm and Equivalent Ptnm Stages in Esophageal Squamous Cell Carcinoma Based on the 8th Edition of AJCC Classification

Long-term Survival of Esophageal Squamous Cell Carcinoma after Surgical Treatment in a Large-Scale Retrospective Study from a Single Cancer Center

Prognosis Impact Of Clinical Characteristics In Patients With Inoperable Esophageal Squamous Cell Carcinoma

Outcomes of Endoscopic Submucosal Dissection Vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort

365. PROGNOSTIC COMPARISON OF LYMPHOVASCULAR INVASION AND LYMPH NODE METASTASIS IN ESOPHAGEAL CANCER PATIENTS